Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency

I. Jarosch (Schoenau am Koenigssee, Germany), W. Hitzl (Salzburg, Austria), A. Koczulla (Schoenau am Koenigssee, Germany), M. Wencker (Loerzweiler, Germany), T. Welte (Hannover, Germany), R. Gloeckl (Schoenau am Koenigssee, Germany), S. Janciauskiene (Hannover, Germany), K. Kenn (Schoenau am Koenigssee, Germany)

Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content
Session: Latest advances in pulmonary rehabilitation assessment and content
Session type: Oral Presentation
Number: 5198
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Jarosch (Schoenau am Koenigssee, Germany), W. Hitzl (Salzburg, Austria), A. Koczulla (Schoenau am Koenigssee, Germany), M. Wencker (Loerzweiler, Germany), T. Welte (Hannover, Germany), R. Gloeckl (Schoenau am Koenigssee, Germany), S. Janciauskiene (Hannover, Germany), K. Kenn (Schoenau am Koenigssee, Germany). Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency. 5198

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Differences in training response between patients with alpha-1 antitrypsin deficiency and COPD patients
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015

Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD)
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010


Comparison of outcomes in augmentation naïve and augmented patients with alpha-1 antitrypsin deficiency related lung disease.
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019


Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Characteristics of COPD patients and alpha-1 antitrypsin deficiency at outpatient respiratory clinics. The EPOCONSUL study.
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study
Source: Eur Respir J 2005; 26: Suppl. 49, 361s
Year: 2005

Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in!
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Lung function in relation to emphysema development in alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


Clinical features of alpha one antitrypsin deficiency in COPD
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

GSTP1 polymorphisms in patients with COPD and alpha-1 antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 384s
Year: 2003

Substitution therapy in Alpha-1 antitrypsin deficiency after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Alpha-1 antitrypsin deficiency and pulmonary morbidity in patients with primary immunodeficiency disease: A single center experience
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018

Endobronchial valve treatment in patients with severe emphysema due to alpha-1 antitrypsin deficiency.
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019

Alpha-1 antitrypsin deficiency severity and the risk of COVID-19
Source: Virtual Congress 2021 – Burden and epidemiology of COVID-19
Year: 2021


COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Relationship between atopy, asthma and alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019


Investigating change in the COPD assessment test (CAT) within α-1 antitrypsin deficiency (A1ATD)
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011